Sentences with phrase «business acquisition transactions»

Jay is an SBA Loan Specialist who works with small businesses to structure bank financing for business acquisition transactions, business expansion and cash flow maximization.

Not exact matches

The two transactions highlight just how risky the mergers - and - acquisitions business, a standout performer in 2015, has become.

Actual results, including with respect to our targets and prospects, could differ materially due to a number of factors, including the risk that we may not obtain sufficient orders to achieve our targeted revenues; price competition in key markets; the risk that we or our channel partners are not able to develop and expand customer bases and accurately anticipate demand from end customers, which can result in increased inventory and reduced orders as we experience wide fluctuations in supply and demand; the risk that our commercial Lighting Products results will continue to suffer if new issues arise regarding issues related to product quality for this business; the risk that we may experience production difficulties that preclude us from shipping sufficient quantities to meet customer orders or that result in higher production costs and lower margins; our ability to lower costs; the risk that our results will suffer if we are unable to balance fluctuations in customer demand and capacity, including bringing on additional capacity on a timely basis to meet customer demand; the risk that longer manufacturing lead times may cause customers to fulfill their orders with a competitor's products instead; the risk that the economic and political uncertainty caused by the proposed tariffs by the United States on Chinese goods, and any corresponding Chinese tariffs in response, may negatively impact demand for our products; product mix; risks associated with the ramp - up of production of our new products, and our entry into new business channels different from those in which we have historically operated; the risk that customers do not maintain their favorable perception of our brand and products, resulting in lower demand for our products; the risk that our products fail to perform or fail to meet customer requirements or expectations, resulting in significant additional costs, including costs associated with warranty returns or the potential recall of our products; ongoing uncertainty in global economic conditions, infrastructure development or customer demand that could negatively affect product demand, collectability of receivables and other related matters as consumers and businesses may defer purchases or payments, or default on payments; risks resulting from the concentration of our business among few customers, including the risk that customers may reduce or cancel orders or fail to honor purchase commitments; the risk that we are not able to enter into acceptable contractual arrangements with the significant customers of the acquired Infineon RF Power business or otherwise not fully realize anticipated benefits of the transaction; the risk that retail customers may alter promotional pricing, increase promotion of a competitor's products over our products or reduce their inventory levels, all of which could negatively affect product demand; the risk that our investments may experience periods of significant stock price volatility causing us to recognize fair value losses on our investment; the risk posed by managing an increasingly complex supply chain that has the ability to supply a sufficient quantity of raw materials, subsystems and finished products with the required specifications and quality; the risk we may be required to record a significant charge to earnings if our goodwill or amortizable assets become impaired; risks relating to confidential information theft or misuse, including through cyber-attacks or cyber intrusion; our ability to complete development and commercialization of products under development, such as our pipeline of Wolfspeed products, improved LED chips, LED components, and LED lighting products risks related to our multi-year warranty periods for LED lighting products; risks associated with acquisitions, divestitures, joint ventures or investments generally; the rapid development of new technology and competing products that may impair demand or render our products obsolete; the potential lack of customer acceptance for our products; risks associated with ongoing litigation; and other factors discussed in our filings with the Securities and Exchange Commission (SEC), including our report on Form 10 - K for the fiscal year ended June 25, 2017, and subsequent reports filed with the SEC.

The company confirmed Thursday it is in «active discussions regarding a transaction that would result in an acquisition of the entire Canadian business,» as the U.S. company seeks approval in its bankruptcy proceedings for the sale of its equity interest in the Canadian business.

Readers are cautioned that these forward - looking statements are only predictions and may differ materially from actual future events or results due a variety of factors, including, among other things, that conditions to the closing of the transaction may not be satisfied, the potential impact on the business of Accompany due to the uncertainty about the acquisition, the retention of employees of Accompany and the ability of Cisco to successfully integrate Accompany and to achieve expected benefits, business and economic conditions and growth trends in the networking industry, customer markets and various geographic regions, global economic conditions and uncertainties in the geopolitical environment and other risk factors set forth in Cisco's most recent reports on Form 10 - K and Form 10 - Q.

As with other high - profile Chinese deals (such as Shuanhui's acquisition of Smithfield Foods for $ 4.7 billion in May 2013), the Waldorf Astoria transaction raises important business and policy questions: what is driving Chinese foreign direct investment (FDI) and what is the best response to this important development?

The acquisition price implies a total equity value of approximately $ 52.4 billion and a total transaction value of approximately $ 66.1 billion (in each case based on the stated exchange ratio assuming no adjustment) for the business to be acquired by Disney, which includes consolidated assets along with a number of equity investments.

Prior to joining Carrick, he was an investment banking analyst at Credit Suisse where he focused on mergers and acquisitions and capital raise transactions for business services and industrials clients.

Such risks and uncertainties include, but are not limited to: our ability to achieve our financial, strategic and operational plans or initiatives; our ability to predict and manage medical costs and price effectively and develop and maintain good relationships with physicians, hospitals and other health care providers; the impact of modifications to our operations and processes; our ability to identify potential strategic acquisitions or transactions and realize the expected benefits of such transactions, including with respect to the Merger; the substantial level of government regulation over our business and the potential effects of new laws or regulations or changes in existing laws or regulations; the outcome of litigation, regulatory audits, investigations, actions and / or guaranty fund assessments; uncertainties surrounding participation in government - sponsored programs such as Medicare; the effectiveness and security of our information technology and other business systems; unfavorable industry, economic or political conditions, including foreign currency movements; acts of war, terrorism, natural disasters or pandemics; our ability to obtain shareholder or regulatory approvals required for the Merger or the requirement to accept conditions that could reduce the anticipated benefits of the Merger as a condition to obtaining regulatory approvals; a longer time than anticipated to consummate the proposed Merger; problems regarding the successful integration of the businesses of Express Scripts and Cigna; unexpected costs regarding the proposed Merger; diversion of management's attention from ongoing business operations and opportunities during the pendency of the Merger; potential litigation associated with the proposed Merger; the ability to retain key personnel; the availability of financing, including relating to the proposed Merger; effects on the businesses as a result of uncertainty surrounding the proposed Merger; as well as more specific risks and uncertainties discussed in our most recent report on Form 10 - K and subsequent reports on Forms 10 - Q and 8 - K available on the Investor Relations section of www.cigna.com as well as on Express Scripts» most recent report on Form 10 - K and subsequent reports on Forms 10 - Q and 8 - K available on the Investor Relations section of www.express-scripts.com.

Services Advisory Assurance Attest Services Audit, Reviews & Compilations Employee Benefit Plan Audits Internal Audit Services International Financial Reporting Standards (IFRS) IT Audit Services SEC Services SOC 1 and 2 Services Statutory Financial Audits Tax Accounting Methods Cost Segregation Estate Tax Credits Executive Compensation Federal Corporate Tax Generational Wealth Planning International Tax Mergers & Acquisitions Real Estate Research & Development Tax Credits Sales and Use Tax State & Local Tax Tax Accounting Tax Reform Transfer Pricing Business Support DHG Search DHG Staffing Forensics Commercial Damages Digital & Computer Forensics Domestic Matters Fraud & Corporate Investigations Personal Damages Healthcare Consulting Alternative Payment Models Center For Industry Transformation Points Beyond Blog CFO Advisory Bundled Payment Models Clinical Documentation Improvement Enterprise Intelligence iluminus Reimbursement Revenue Cycle Senior Living Strategy Physician Enterprise Optimization International Services Chinese Business Services Japanese Business Services Investment Management DHG Agency DHG Wealth Advisors IT Advisory Retirement Plan Administration Risk Advisory Finance & Process Transformation Internal Audit & Compliance Regulatory Services & Risk Management Technology Services Transaction Advisory Valuation Services Financial Reporting Healthcare Valuations

Known for her quick and direct approach, Jessie is skilled in financing business acquisitions, partnership buyouts, refinancing, and various other sophisticated business transactions.

Factors that could cause actual results to differ materially from those expressed or implied in any forward - looking statements include, but are not limited to: changes in consumer discretionary spending; our eCommerce platform not producing the anticipated benefits within the expected time - frame or at all; the streamlining of the Company's vendor base and execution of the Company's new merchandising strategy not producing the anticipated benefits within the expected time - frame or at all; the amount that we invest in strategic transactions and the timing and success of those investments; the integration of strategic acquisitions being more difficult, time - consuming, or costly than expected; inventory turn; changes in the competitive market and competition amongst retailers; changes in consumer demand or shopping patterns and our ability to identify new trends and have the right trending products in our stores and on our website; changes in existing tax, labor and other laws and regulations, including those changing tax rates and imposing new taxes and surcharges; limitations on the availability of attractive retail store sites; omni - channel growth; unauthorized disclosure of sensitive or confidential customer information; risks relating to our private brand offerings and new retail concepts; disruptions with our eCommerce platform, including issues caused by high volumes of users or transactions, or our information systems; factors affecting our vendors, including supply chain and currency risks; talent needs and the loss of Edward W. Stack, our Chairman and Chief Executive Officer; developments with sports leagues, professional athletes or sports superstars; weather - related disruptions and seasonality of our business; and risks associated with being a controlled company.

If we develop a reputation for being a difficult acquirer or having an unfavorable work environment, or target companies view our non-voting Class A common stock unfavorably, we may be unable to consummate key acquisition transactions essential to our corporate strategy and our business may be seriously harmed.

Ms. Crouse provides business - focused advice and solutions for U.S. federal, state, and international tax considerations pertinent to mergers and acquisitions, corporate divestitures, internal reorganizations, cross-border transactions, private equity and venture capital fund creation and investments, and organization, operation, and sale of start - up companies.

After reaching an agreement with a buyer or seller for the acquisition or disposition of a business, we are subject to satisfaction of pre-closing conditions as well as to necessary regulatory and governmental approvals on acceptable terms, which, if not satisfied or obtained, may prevent us from completing the transaction.

She advises corporations, boards of directors, investors, CEOs and CFOs, and business owners on a wide range of corporate and securities transactions, including mergers and acquisitions, securities offerings, venture capital, joint ventures, and corporate finance.

New Dole looks to be massively undervalued, will still hold very good high value assets, especially saleable land, has some future potential catalysts that could help unlock value, it should be able to compete better with Fresh Del Monte and Chiquita, and new Dole will now be freed up to make acquisitions and improvements to its business and operations after the transaction with Itochu closes as it will not be burdened by the massive amount of debt that it has carried for years.

Arlene also advises her clients — particularly startup and emerging growth companies — on their general business concerns, including merger and acquisition transactions.

Prior to co-founding Oberon in 2001, Elad was with Deutsche Bank Securities Inc. in the Mergers and Acquisitions Group where he executed numerous transactions, primarily in the business services, technology, and chemicals sectors.

Corporate Practice: Business entity formation, venture capital fund formation, start - up representation, contracts, equity & debt financings, EB5 - investment based immigration, venture capital financings, tax exempt bond financings, nonprofit formation & tax exemption, mergers & acquisitions, technology transactions, licensing.

Cautionary Note Regarding Forward Looking Statements: Certain disclosure in this release, including statements regarding the acquisition by the Company of the NODE40 Business and GCPA (the «Transactions»), including the anticipated benefits to the Company of the Transactions, the performance of 5,000 Rigs ordered by the Company, the expected timing of delivery and installation of 770 Rigs and expectations regarding future operations may constitute forward - looking statements.

In making the forward - looking statements in this release, the Company has applied certain factors and assumptions that are based on the Company's current beliefs as well as assumptions made by and information currently available to the Company, including that all conditions to the closing of the Transactions will be satisfied, including receipt of all required approvals, and the Transactions will complete on the terms set out in the APA and the SPA, the acquisition of the NODE40 Business will have the benefits to the Company anticipated by management, the 5,000 Rigs will be successfully ordered and delivered, the 5,000 Rigs will perform as expected by management and the timing, installation and performance of the 770 Rigs will be consistent with management's expectations.

We have worked on international tax - planning strategies and transactions, international tax consequences of cross-border acquisitions and dispositions of businesses, dual consolidated losses, the maximum utilization of foreign tax credits, Subpart F taxation, transfer pricing, VAT, the PFIC rules, sourcing of income, and the FIRPTA rules.

We may use and / or disclose your Personally Identifiable Information for the following reasons: to contact you in response to your inquiries, comments and suggestions; to contact you otherwise when necessary; for the specific purpose for which it was volunteered; to track our visitors» use of the site for internal market research; to improve the site and the services Phoenix Media Corporation promotes or provides through the site; to customize the content and / or layout of our site for each individual visitor; to ask for your participation in brief surveys; to complete any purchases or other transactions you may perform on the site; to notify visitors about updates to the sites or services; to notify you about promotions, special offers, etc. regarding products and services provided by Phoenix Media Corporation or its affiliates or partners; to be provided to Phoenix Media Corporation affiliates or third parties in connection with the legitimate business purposes of Phoenix Media Corporation or the site; to be provided to third parties for the legitimate business purposes of those third parties; to generate aggregate statistical studies; as required by law or regulation, or as requested by government authorities, or for the protection of persons or property; and in connection with an acquisition, merger, restructuring, sale or other transfer involving all or any portion of the business associated with the site; and for other business purposes.

The proposed acquisition includes three Reckon businesses: - Reckon APS - Reckon Elite - Reckon Docs The transaction includes all associated clients, IP, systems and employees for these businesses.

Currently EU imports (known as «acquisitions») are generally cash flow neutral and are reported by businesses via a self assessed VAT return as nothing more than an accounting transaction.

Previously, Torsten worked for more than 10 years at GlaxoSmithKline Vaccines where he was the Global Head of the Vaccines Transactions Team with responsibility for all vaccine business development activities ranging from collaborations, option and licensing contracts to mergers & acquisitions.

Actual results could differ materially for a variety of reasons, including, in addition to the factors discussed above, the amount that Amazon.com invests in new business opportunities and the timing of those investments, the mix of products sold to customers, the mix of net sales derived from products as compared with services, the extent to which we owe income taxes, competition, management of growth, potential fluctuations in operating results, international growth and expansion, the outcomes of legal proceedings and claims, fulfillment center optimization, risks of inventory management, seasonality, the degree to which the Company enters into, maintains and develops commercial agreements, acquisitions and strategic transactions, and risks of fulfillment throughput and productivity.

Actual results could differ materially for a variety of reasons, including, in addition to the factors discussed above, the amount that Amazon.com invests in new business opportunities and the timing of those investments, the mix of products sold to customers, the mix of net sales derived from products as compared with services, the extent to which we owe income taxes, competition, management of growth, potential fluctuations in operating results, international growth and expansion, the outcomes of legal proceedings and claims, fulfillment and data center optimization, risks of inventory management, seasonality, the degree to which the Company enters into, maintains and develops commercial agreements, acquisitions and strategic transactions, and risks of fulfillment throughput and productivity.

The Offer is conditioned upon, among other things, (i) the Nominees being elected to the Board at the Special Meeting or otherwise being appointed to, and constituting a majority of, the members of the Board, (ii) the Board redeeming the «poison pill,» or our being satisfied in our reasonable discretion that the «poison pill» is otherwise inapplicable to the Offer, the BVF Group or any affiliates or associates of the BVF Group, and (iii) Avigen not having authorized, recommended, proposed, announced its intent to enter into or entered into an agreement with respect to or effected any merger, consolidation, liquidation, dissolution, business combination, acquisition of assets, disposition of assets, alternative strategy or relinquishment of any material contract or other right of Avigen or any comparable event or capital depleting transaction not in the ordinary course of business.

The tender offer is conditioned upon, among other things, (i) the BVF Nominees being elected to Avigen's board of directors at a special meeting of stockholders called for that purpose, or otherwise appointed, and constituting a majority of directors on Avigen's board, (ii) the Avigen board redeeming the poison pill rights issued and outstanding under Avigen's Poison Pill Rights Plan, or the Purchaser being satisfied in its reasonable discretion that the Poison Pill Rights are otherwise inapplicable to this tender offer, the Purchaser or any affiliate or associate of the Purchaser and (iii) Avigen not having authorized, recommended, proposed, announced its intent to enter into or entered into an agreement with respect to or effected any merger, consolidation, liquidation, dissolution, business combination, acquisition of assets, disposition of assets, alternative strategy or relinquishment of any material contract or other right of Avigen or any comparable event or capital depleting transaction not in the ordinary course of business.

Depending on the nature of the business opportunities and the related transactions, a future business acquisition may or may not require stockholder approval.

Incorporated («Morgan Stanley») as its advisor to assist the Company in exploring strategic alternatives available to the Company for enhancing shareholder value, including but not limited to, continued execution of the Company's business plan, the payment of a cash dividend to the Company's shareholders, a repurchase by the Company of shares of its capital stock, the sale or spin off of Company assets, partnering or other collaboration agreements, a merger, sale or liquidation of, or acquisition by, the Company or other strategic transaction.

The Board made this decision after completing an exhaustive evaluation of various strategic alternatives available to the Company for enhancing stockholder value, including but not limited to, continued execution of the Company's business plan, the payment of a cash dividend to the Company's stockholders, a repurchase by the Company of shares of its capital stock, the sale or spin off of Company assets, partnering or other collaboration agreements, a merger, sale or liquidation of, or acquisition by, the Company or other strategic transaction.

He represents U.S. - based and international public and private companies, as well as investors, in connection with corporate transactions, including domestic and cross-border mergers and acquisitions, venture capital financings, joint ventures, and international business transactions.

The acquisition represents one of dnata's biggest business transactions in the company's 52 year history.

This transaction is the acquisition of all assets and liabilities of Unicorn Enterprise Co., Ltd., a wholly owned subsidiary of BTS Group Holdings Public Company Limited, engaging in the property business through the Entire Business Transfer tranbusiness through the Entire Business Transfer tranBusiness Transfer transaction.

These include corporate formation and financing, securities, mergers and acquisitions, technology transactions, privacy, business litigation, insurance recovery litigation and counseling, labor and employment litigation and counseling, energy, oil and gas, consumer regulatory and litigation matters, commercial and real estate lending, real estate development and commercial and real estate workouts.

Ralph Dyer practices primarily in the areas of corporate and business law, including corporate formation, mergers and acquisitions and corporate transactions as well as employment law.

His transactional practice includes mergers, acquisitions and dispositions of businesses, debt and equity financings, angel investments, private equity sponsored transactions, management buyouts, succession planning arrangements and corporate reorganizations.

Whether real estate is their primary business or an important asset, clients turn to our highly experienced team to handle real estate acquisitions, dispositions, investments, financing, development and leasing matters, as well as to handle disputes that may arise in the course of such transactions.

The in - depth experience our business lawyers have in complex transactions enables us to assist our clients — as both IP licensors and licensees — with negotiations and deal structuring, and in connection with business acquisitions, financings, joint ventures and strategic alliances involving IP.

An early interest in business law ultimately led Reggie Clark to Eversheds Sutherland (US)'s Tax Practice Group, where he counsels a variety of corporate clients on the complex tax issues that affect corporate acquisitions, restructurings, spinoffs and other transactions.

Counseling numerous financial institutions, private equity funds and other business enterprises in scores of public and private mergers, acquisitions, dispositions, joint ventures and consortium transactions, including in traditional and distressed circumstances.

Mr. Talamantes, who is a native of Mexico and fluent in Spanish and English, handles a wide variety of domestic and international business transactions and industries, including project development, joint ventures, acquisitions, and divestitures in the oil, gas, and electricity industries.

He advises private and public companies on legal issues ranging from entity formation, operations, employee matters, and contract preparation and negotiation to corporate finance and business combination transactions, including securities offerings, debt and equity financing transactions, mergers, stock / asset acquisitions, and other corporate partnering transactions.

As well recognized Toronto business lawyers provide legal services for all matters in Business Law, Shareholder Disputes, Partnerships, Litigation, Corporate Law, legal and strategic expertise including mergers and acquisitions, public and private company reorganizations, major transactions, corporate governance, directors» & officers» duties & liabilities, disclosure and business strubusiness lawyers provide legal services for all matters in Business Law, Shareholder Disputes, Partnerships, Litigation, Corporate Law, legal and strategic expertise including mergers and acquisitions, public and private company reorganizations, major transactions, corporate governance, directors» & officers» duties & liabilities, disclosure and business struBusiness Law, Shareholder Disputes, Partnerships, Litigation, Corporate Law, legal and strategic expertise including mergers and acquisitions, public and private company reorganizations, major transactions, corporate governance, directors» & officers» duties & liabilities, disclosure and business strubusiness structuring.

Alan represents public and private domestic and international companies and entrepreneurs in all facets of general business, corporate and securities matters, including public and private equity and debt offerings, mergers and acquisitions, business contracts, business transactions, joint ventures, corporate governance, and franchise matters.

She also works with clients involved in mergers and acquisitions to assess and evaluate the labor and employment liabilities associated with a specific transaction, and to develop business - oriented and creative solutions to issues that may arise in any given transaction.

We have a long track record of advising clients in the food and beverage industry on a wide range of matters, from labeling and FDA regulatory compliance to significant transactions such as strategic investments, acquisitions and dispositions of businesses.